Tyrosine kinase inhibitors: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
Michael (talk | contribs)
49,358 edits
No edit summary
Michael (talk | contribs)
49,358 edits
No edit summary
Line 7: Line 7:


Others - used in [[RCC]]:<ref>URL: [http://dtb.bmj.com/content/49/11/129.abstract http://dtb.bmj.com/content/49/11/129.abstract]. Accessed on: 3 October 2014</ref>
Others - used in [[RCC]]:<ref>URL: [http://dtb.bmj.com/content/49/11/129.abstract http://dtb.bmj.com/content/49/11/129.abstract]. Accessed on: 3 October 2014</ref>
* Sunitinib (Sutent).
* [[Sunitinib]] (Sutent).
* Sorafenib (Nexavar).
* Sorafenib (Nexavar).
* Pazopanib (Votrient).  
* Pazopanib (Votrient).  
Retrieved from "https://librepathology.org/wiki/Tyrosine_kinase_inhibitors"